May’s top news stories


Abivax unveiled new data that may suggest its clinical candidate ABX464 could be a safe, functional cure for human immunodeficiency virus (HIV). Credit: Shutterstock.



nurse talking, making notes

Cancer Research UK Clinical Trials Unit at the University of Birmingham started a Phase I trial for leukaemia. Credit: Cancer Research UK.



A healthy volunteer received an IV infusion of mAb114. Credit: NIAID.


https://www.drugdevelopment-technology.com/features/2018-may-top-stories-drug/

by